Suzhou Basecare Medical Corporation Limited Stock
Equities
2170
CNE100004BC1
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 HKD | -2.17% | +5.63% | -4.26% |
Sales 2024 * | 459M 63.45M 496M | Sales 2025 * | - | Capitalization | 580M 80.32M 628M |
---|---|---|---|---|---|
Net income 2024 * | -78M -10.79M -84.37M | Net income 2025 * | - | EV / Sales 2024 * | 1.27 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.21
x | P/E ratio 2025 * |
-
| Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.54% |
1 day | -2.17% | ||
1 week | +3.21% | ||
Current month | +5.63% | ||
1 month | +4.17% | ||
3 months | +7.14% | ||
6 months | -21.88% | ||
Current year | -4.26% |
Managers | Title | Age | Since |
---|---|---|---|
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Le Jun Yin
DFI | Director of Finance/CFO | 39 | 22-11-27 |
Mao She Rui
COO | Chief Operating Officer | 36 | 14-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Xiong Kang
BRD | Director/Board Member | 72 | 21-01-15 |
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Ling Yin Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 11-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.25 | -2.17% | 6 500 |
24-05-07 | 2.3 | -0.43% | 20,500 |
24-05-06 | 2.31 | 0.00% | 182,000 |
24-05-03 | 2.31 | +5.96% | 95,000 |
24-05-02 | 2.18 | +2.35% | 115,000 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.26% | 80.44M | |
-17.21% | 8.46B | |
+50.91% | 3.88B | |
-34.71% | 2.63B | |
-8.41% | 2.45B | |
-9.64% | 2.31B | |
-3.77% | 1.99B | |
-17.29% | 1.61B | |
-36.54% | 1.3B | |
+5.98% | 1.09B |
- Stock Market
- Equities
- 2170 Stock